Product Information

LUPRON DEPOT 11.25 MG 3MO KIT is a brand product labeled by AbbVie Inc., priced at $5430.9275 per EA under NDC 00074366303. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Mar 7, 1997.

The High Outlier badge above means this manufacturer's average price in the leuprolide acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LUPRON DEPOT 11.25 MG 3MO KIT

leuprolide acetate
$5430.9275per EA
High Outlier

Manufacturer

AbbVie Inc.

NDC

00074366303

Classification

Brand

Dosage Form

KIT

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA020708

FDA Approved

3/7/1997

On Market Since

11/8/2010

Price Statistics

The NADAC for LUPRON DEPOT 11.25 MG 3MO KIT has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 134.5%. The table below summarizes its recorded NADAC range and movement.

Current price$5430.9275 per EA
All-time high$5464.0546 (Jun 10, 2026)
All-time low$2316.0783 (Nov 28, 2013)
52-week high$5464.0546
52-week low$5201.8736
Median price$4034.4830
Average price$3942.5215
Largest weekly change+9.4% (Jan 10, 2018)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.1%

1M

-0.1%

3M

-0.6%

6M

-0.6%

1Y

+4.3%

3Y

+13.8%

5Y

+25.3%

All

+134.5%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of LUPRON DEPOT 11.25 MG 3MO KIT?

The current National Average Drug Acquisition Cost (NADAC) for LUPRON DEPOT 11.25 MG 3MO KIT, manufactured by AbbVie Inc., is $5430.9275 per EA (NDC 00074366303), effective Aug 19, 2026.

How has the price of LUPRON DEPOT 11.25 MG 3MO KIT changed over time?

Over the history we have for it, the NADAC for LUPRON DEPOT 11.25 MG 3MO KIT has risen 134.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LUPRON DEPOT 11.25 MG 3MO KIT?

Since Nov 28, 2013, the NADAC for LUPRON DEPOT 11.25 MG 3MO KIT has ranged from a low of $2316.0783 (Nov 28, 2013) to a high of $5464.0546 (Jun 10, 2026), with a median of $4034.4830 per EA.

Are there cheaper alternatives to LUPRON DEPOT 11.25 MG 3MO KIT?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEUPROLIDE 2WK 14 MG/2.8 ML KT, is $197.6060 per EA — about 96% below LUPRON DEPOT 11.25 MG 3MO KIT.

Who manufactures LUPRON DEPOT 11.25 MG 3MO KIT?

LUPRON DEPOT 11.25 MG 3MO KIT (NDC 00074366303) is labeled by AbbVie Inc., and CMS classifies it as a brand product.